LegiPlex
AI Workspace & Legislation Tracker
Creaet A Workspace
About
Sign Up
Login
Research Tools
Keyword Search
Bill Content
Video & Transcript
Capitol Directory (Beta)
US
Utah UT
Legislatures
2025 Regular Session
Senate
Bills
SB0248
UT
Utah Senate Bill SB0248
Overview
Activity Timeline
Authors & Sponsors
Committee Assignments
Draft Versions & Texts
Latest Draft
Compare Versions
View All
Official Action Record
Calendar
Utah 2025 Regular Session
Utah Senate Bill SB0248
Introduced
2/11/25
Refer
2/26/25
Report Pass
2/28/25
Failed
3/7/25
Caption
Controlled Substances Amendments
Latest SB0248 Activity
Companion Bills
No companion bills found.
Previously Filed As
UT HB0260
Controlled Substances Amendments
UT HB0576
Controlled Substance Revisions
UT SB0200
Psilocybin Recommendation Pilot Program Amendments
UT SB0024
Physician Assistant Practice Amendments
UT SB0229
Health and Human Services Licensing Amendments
UT SB0188
Inmate Amendments
UT SB0207
Pharmacy Practice Act Amendments
UT SB0254
Drug-induced Homicide Amendments
UT SB0036
Professional Licensing Amendments
UT HB0369
DUI Amendments
Similar Bills
CA AB2589
Controlled substances: human chorionic gonadotropin.
CA AB2783
Controlled substances: hydrocodone combination products: schedules.
CA SB1502
Controlled substances: xylazine.
CA AB527
Controlled substances.
MS HB1342
Controlled substances; bring forward sections for unlawful possession of.
NJ S3902
Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances.
NJ A5448
Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances.
NJ S191
Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances.